Scarica l'app Stockscreener
72.29
0.01%
0.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie
Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report? - Zacks Investment Research
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar - Zacks Investment Research
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises - Zacks Investment Research
ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts - Yahoo Finance
Form 4 ANI Pharmaceuticals Inc For: 1 October By Investing.com - Investing.com Nigeria
Ani Pharmaceuticals SVP & CFO Stephen Carey sells $208,050 in stock - Investing.com
ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts - Yahoo! Finance Canada
ANI Pharmaceuticals (NASDAQ:ANIP) Stock: Insider Stephen Carey Sells 2,850 Shares - MarketBeat
After selling 2,850 shares, ANI Pharmaceuticals (ANIP) CFO holds 168,993 shares. - Stock Titan
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Price, News, Quote & History - Yahoo! Finance Canada
ANI Pharmaceuticals Announces New Fluocinolone Acetonide - GlobeNewswire
Data on an eye implant for chronic eye inflammation will be presented in a late-breaking talk Oct. 9. - Stock Titan
ANI Pharmaceuticals, Inc. (ANIP) Stock Price, News, Quote & History - Yahoo! Finance Canada
Implied Volatility Surging for ANI Pharmaceuticals Stock Options - Yahoo Finance UK
Implied Volatility Surging for ANI Pharmaceuticals Stock Options - TradingView
Implied Volatility Surging for ANI Pharmaceuticals Stock Options - Yahoo! Finance Canada
183,066 Shares of ANI Pharmaceuticals, Inc. $ANIP Acquired by Bank of America Corp DE - MarketBeat
ANIP5868601 Bond Profile: Coupon and Redemption - TradingView
ANI Pharmaceuticals: Cortrophin’s Q4 Test, With Generics Funding The Build (NASDAQ:ANIP) - Seeking Alpha
ANI Pharmaceuticals, Inc. (ANIP) Stock forecasts - Yahoo Finance Singapore
ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts - Yahoo Finance
Ocular Therapeutix and ANI Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance
ANI Pharmaceuticals gets FDA approval for generic everolimus - Investing.com
Oppenheimer initiates ANI Pharmaceuticals stock with Perform rating - Investing.com
ANI Pharmaceuticals Receives FDA Approval for Generic Everolimus Tablets for Oral Suspension - Quiver Quantitative
ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension - Yahoo Finance
ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension - GlobeNewswire
Oppenheimer Initiates ANI Pharmaceuticals at Perform With $85 Price Target - Yahoo Finance
ANI Pharmaceuticals (NasdaqGM:ANIP) Stock Forecast & Analyst Predictions - simplywall.st
ANI Pharmaceuticals (ANIP) Reports Next Week: Wall Street Expects Earnings Growth - Eastern Progress
ANI Pharmaceuticals (ANIP) CEO sells 5,400 shares in pre-set trading plan - Stock Titan
ANI Pharmaceuticals (NASDAQ: ANIP) insider lines up $380,000 stock sale for 2026 - Stock Titan
ANI Pharmaceuticals (ANIP) insider sells 500 shares - Stock Titan
Ani Pharmaceuticals’ Meredith Cook sells $35,395 in common stock - Investing.com
ANI Pharmaceuticals (ANIP) director sells 1,000 shares in planned trade - Stock Titan
VIRGINIA RETIREMENT SYSTEMS ET Al Acquires New Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
ANI Pharmaceuticals (NASDAQ: ANIP) director plans $71K share sale - Stock Titan
WINTON GROUP Ltd Takes $4.56 Million Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals at Wells Fargo conference: rare disease push gains pace - Investing.com Canada
ANI Pharmaceuticals stock hits 52-week low at 70.03 USD By Investing.com - Investing.com Nigeria
ANI Pharmaceuticals stock hits 52-week low at 70.03 USD By Investing.com - Investing.com South Africa
ETFs Investing in ANI Pharmaceuticals, Inc. Stocks - tradingview.com
ANI Pharmaceuticals (NASDAQ:ANIP) Sets New 52-Week LowTime to Sell? - MarketBeat
ANI Pharmaceuticals stock hits 52-week low at 70.03 USD - investing.com
ANI Pharmaceuticals (NASDAQ:ANIP) Earns Outperform Rating from Analysts at Leerink Partners - MarketBeat
Legal & General Group Plc Buys Shares of 45,075 ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board - Yahoo Finance
ANI Pharmaceuticals to Present at September Investor Conferences - The Manila Times
ANI Pharmaceuticals to Present at September Investor Conferences - Yahoo Finance
2.21%
5.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):